Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5284517
Max Phase: Preclinical
Molecular Formula: C18H22ClN9O7S
Molecular Weight: 543.95
Associated Items:
ID: ALA5284517
Max Phase: Preclinical
Molecular Formula: C18H22ClN9O7S
Molecular Weight: 543.95
Associated Items:
Canonical SMILES: Nc1ncnc2c1ncn2[C@@H]1O[C@H](CN(CC[C@H](N)C(=O)O)S(=O)(=O)c2cnc(Cl)cn2)[C@@H](O)[C@H]1O
Standard InChI: InChI=1S/C18H22ClN9O7S/c19-10-3-23-11(4-22-10)36(33,34)27(2-1-8(20)18(31)32)5-9-13(29)14(30)17(35-9)28-7-26-12-15(21)24-6-25-16(12)28/h3-4,6-9,13-14,17,29-30H,1-2,5,20H2,(H,31,32)(H2,21,24,25)/t8-,9+,13+,14+,17+/m0/s1
Standard InChI Key: NUFHSMQFUWVWAB-ACSHICKMSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 543.95 | Molecular Weight (Monoisotopic): 543.1051 | AlogP: -2.04 | #Rotatable Bonds: 9 |
Polar Surface Area: 245.79 | Molecular Species: ZWITTERION | HBA: 14 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 16 | HBD (Lipinski): 7 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 2.00 | CX Basic pKa: 9.09 | CX LogP: -4.88 | CX LogD: -4.88 |
Aromatic Rings: 3 | Heavy Atoms: 36 | QED Weighted: 0.20 | Np Likeness Score: 0.13 |
1. Schwickert M, Zimmermann RA, Habeck T, Hoba SN, Nidoieva Z, Fischer TR, Stark MM, Kersten C, Lermyte F, Helm M, Schirmeister T.. (2023) Covalent S-Adenosylhomocysteine-Based DNA Methyltransferase 2 Inhibitors with a New Type of Aryl Warhead., 14 (6): [PMID:37312859] [10.1021/acsmedchemlett.3c00062] |
Source(1):